High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study

The worldwide pandemic of 2019 novel coronavirus disease (COVID-19) has posed the most substantial and severe public health issue for several generations, and therapeutic options have not yet been optimised. Vitamin D (in its “parent” form, cholecalciferol) has been proposed in the pharmacological m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Stephanie F., Broad, Eleanor, Murphy, Rebecca, Pappachan, Joseph M., Pardesi-Newton, Satveer, Kong, Marie-France, Jude, Edward B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763301/
https://www.ncbi.nlm.nih.gov/pubmed/33322317
http://dx.doi.org/10.3390/nu12123799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763301/
https://www.ncbi.nlm.nih.gov/pubmed/33322317
http://dx.doi.org/10.3390/nu12123799

Ejemplares similares